Newly launched IBX Alzheimer’s Risk Test predicts the risk of cognitive decline due to Alzheimer’s disease from a simple saliva sample. This genetic test looks at over 100,000 gene variations that are protective against and associated with Alzheimer’s. Use the results to guide your patients on actions they can take to delay the onset of symptoms.

Email:  alzheimers@vanguardpharma.com

Contact:  Erica Jalil